The Academy is sharing important ophthalmology-specific information related to the new 2019-nCoV coronavirus, referred to as “2019-nCoV,” or simply the “Wuhan coronavirus.” Source: AAO
This study assessed the efficacy of recombinant human nerve growth factor therapy cenegermin (Oxervate) for neurotrophic keratopathy. Source: AAO
The authors of this prospective trial investigated whether Scheimpflug tomography could be used to predict the prognosis of Fuchs endothelial corneal dystrophy. Source: AAO
This week, a woman earns jail time for poisoning her husband with Visine, a self-moisturizing contact lens to combat dry eye and Mojo Vision reveals their plans for the world’s first smart contact lens. Source: AAO
This retrospective study characterized and classified central visual field loss that occurs in end-stage glaucoma. Source: AAO
This randomized trial assessed the efficacy of vibration in reducing injection site pain for patients undergoing cutaneous cancer removal. Source: AAO
People with thyroid eye disease finally have a nonsurgical option for improving proptosis, thanks to the FDA’s approval of Horizon Therapeutics’ teprotumumab (Tepezza). Source: AAO
This study investigated the structural and functional effects of repeated intravitreal anti-VEGF injections in eyes with preexisting glaucoma or ocular hypertension. Source: AAO
This prospective cohort study compared the performance of 2 trifocal IOLs: the hydrophobic AcrySof PanOptix (Alcon) and the hydrophilic AT LISA tri 839MP (Zeiss). Source: AAO
This week, the first U.S. patient receives Pixium Vision’s wireless subretinal device, MedPage Today unveils its annual physician salary survey and a 4-year-old girl is left blind from flu complications. Source: AAO